|
|
|
|
|
|
|
10.04.26 - 15:54
|
Citi Cuts Docusign to Neutral With a $50 Target: Has the E-Signature Pioneer Lost Its Edge? (24/7 Wall St.)
|
|
|
Citi has cut Docusign (NASDAQ:DOCU) shares to Neutral from Buy, setting a $50 price target that sits just above where the stock is currently trading. With Docusign stock down 36% year-to-date, the downgrade raises a fair question: has the e-signature pioneer lost its edge? The timing is pointed. Docusign stock trades at $44, meaning Citi's ... Citi Cuts Docusign to Neutral With a $50 Target: Has the E-Signature Pioneer Lost Its Edge?...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03.04.26 - 01:15
|
Compliance Week Appoints Dr. Hemma R. Lomax to Advisory Board (PR Newswire)
|
|
|
Docusign's Vice President, Deputy General Counsel and Global Head of Ethics and Compliance joins the board ahead of her featured appearance at Compliance Week National 2026 GREENWICH, Conn., April 2, 2026 /PRNewswire-PRWeb/ -- Compliance Week today announced the appointment of Dr. Hemma R.......
|
|
|
31.03.26 - 20:03
|
Docusign Brings Intelligent Contract Workflows to Slackbot (PR Newswire)
|
|
|
New Docusign integration helps teams move from conversation to completed agreements right within Slack SAN FRANCISCO, March 31, 2026 /PRNewswire/ -- Docusign (Nasdaq: DOCU) today announced a new integration with Slack, which brings its Intelligent Agreement Management (IAM) platform......
|
|
|
31.03.26 - 18:33
|
Docusign: Fiscal 2027 Could Be ′Transition Year′ Despite Double Digit Growth Strategy (Benzinga)
|
|
|
Docusign is aiming for double-digit growth in the long term, but FY27 could be a transition year. Analyst sees limited near-term upside.
Latest Ratings for DOCU
DateFirmActionFromTo Mar 2022Piper SandlerMaintainsNeutral Mar 2022Wolfe ResearchMaintainsPeer Perform Mar 2022Wells FargoMaintainsEqual-Weight
View More Analyst Ratings for DOCU
View the Latest Analyst Ratings
Importance Rank:
1
read more...
|
|
|
|
|
|
|
|
|
|
|
25.03.26 - 13:18
|
DocuSign Aktie: Starke Zahlen und KI-Strategie - jetzt kaufen? (Aktiencheck)
|
|
|
Frankfurt (www.aktiencheck.de) - DocuSign-Aktienanalyse von XTB:
Jens Klatt, Marktanalyst bei XTB, nimmt die Aktie von DocuSign Inc. (ISIN: US2561631068, WKN: A2JHLZ, Ticker-Symbol: DS3, NASDAQ-Symbol: DOCU) unter die Lupe.
Die DocuSign Aktie rücke nach den jüngsten Quartalszahlen wieder verstärkt in den Fokus von Anlegern. [mehr]...
|
|
|
|